References
Beroukhim, R. et al. Nature 463, 899–905 (2010).
Vogelstein, B. et al. Science 339, 1546–1558 (2013).
Leiserson, M.D. et al. Nat. Genet. 47, 106–114 (2015).
Ciriello, G., Cerami, E., Sander, C. & Schultz, N. Genome Res. 22, 398–406 (2012).
Cancer Genome Atlas Network. Nature 490, 61–70 (2012).
Hill, R.M. et al. Cancer Cell 27, 72–84 (2015).
Stengel, A. et al. Blood 124, 251–258 (2014).
Hermeking, H. & Eick, D. Science 265, 2091–2093 (1994).
Wolf, E., Lin, C.Y., Eilers, M. & Levens, D.L. Trends Cell Biol. 25, 241–248 (2015).
Dang, C.V. Cell 149, 22–35 (2012).
Acknowledgements
This work was supported by the Austrian Science Fund (FWF) (grants P20338 and P23284), the Oesterreichische Nationalbank (project 15093) and CANCER-ID, a project funded by the Innovative Medicines Joint Undertaking (IMI JU).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
Supplementary Table 1 (PDF 62 kb)
Rights and permissions
About this article
Cite this article
Ulz, P., Heitzer, E. & Speicher, M. Co-occurrence of MYC amplification and TP53 mutations in human cancer. Nat Genet 48, 104–106 (2016). https://doi.org/10.1038/ng.3468
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3468
- Springer Nature America, Inc.
This article is cited by
-
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
npj Precision Oncology (2024)
-
Obesity-associated changes in molecular biology of primary breast cancer
Nature Communications (2023)
-
Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer
npj Breast Cancer (2022)
-
SCYN: single cell CNV profiling method using dynamic programming
BMC Genomics (2021)
-
Rapid diagnosis and comprehensive bacteria profiling of sepsis based on cell-free DNA
Journal of Translational Medicine (2020)